Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPantheon International Regulatory News (PIN)

Share Price Information for Pantheon International (PIN)

Share Price is delayed by 15 minutes
Get Live Data
402.00    3.00 (0.75%)
Bid:
402.00
Ask:
403.00
Spread: 1.00 (0.249%)
Market Cap: £1.67b
PIN Live PriceLast checked at - London Stock Exchange

Intraday Pantheon International Share Chart

Monthly Performance Update

5 Jan 2024 07:00

RNS Number : 7115Y
Pantheon International PLC
05 January 2024
Β 

5 January 2024

Β 

For immediate release

The information contained in this announcement is restricted and is not for publication, release or distribution in the United States of America, Canada, Australia (other than to persons who are both wholesale clients and professional or sophisticated investors in Australia), Japan, the Republic of South Africa or any other jurisdiction where its release, publication or distribution is or may be unlawful.

Pantheon International Plc

("PIP" or the "Company")

Β 

Performance Update at 30 November 2023

Β 

Performance Update at 30 November 2023

Β 

476.5p NAV per share

-2.5% NAV per share movement for the month

Β£2.3bn Net asset value

Β£7.2m Net portfolio cash flow*

3.9x Financing cover**

+43% Total shareholder return (5Y)***

Β 

Β 

Month to 30 November 2023

Β 

PIP announced an unaudited net asset value ("NAV") per share of 476.5p as at 30 November 2023, a decrease of 12.1p (-2.5%) from the NAV per share as at 31 October 2023.

In the month to 30 November 2023, valuation gains* were +4.8p (+1.0%), investment income* added +0.4p (+0.1%), foreign exchange movements* were -16.3p (-3.4%) and expenses and taxes**** were -1.0p (-0.2%).

PIP's valuation policy for private equity funds is based on the latest valuations reported by the managers of the funds in which PIP has holdings. In the case of PIP's valuation as at 30 November 2023, 8% of reported valuations are dated 30 November 2023 or later, 81% are dated 30 September 2023, 11% are dated 30 June 2023. Of the 8% of valuations dated 30 November 2023 or later, 7.4% reflect the mark-to-market fair value adjustment for PIP's listed company holdings.

At 30 November 2023, PIP's private equity assets stood at Β£2,404m, whilst net available cash balances^ were Β£24m. The Asset Linked Note^^ ("ALN") outstanding as at 30 November 2023 amounted to Β£29m. Undrawn commitments to investments stood at Β£761m as at 30 November 2023, calculated using exchange rates at that date. PIP maintains a five-year Β£500m^^^ multi-tranche, multi-currency revolving credit facility. As at 30 November 2023, Β£121m was drawn down under the loan facility.

Β 

During the month, PIP committed Β£7.5m to two new co-investments:

Β· A Β£5.5m commitment alongside ECI Partners to Commify, a UK-based provider of business messaging solutions to small- and medium-sized businesses.Β 

Β· A Β£2.0m commitment alongside TPG to Denodo, a data management and integration software business, based in the USA.

Β 

Six months to 30 November 2023

Β 

Performance

Β 

The unaudited NAV per share of 476.5p as at 30 November 2023 is an increase of 14.1p (+3.1%) relative to the NAV per share as at 31 May 2023. Valuation gains* added 6.4p (+1.4%), investment income* added +1.8p (+0.4%), foreign exchange movements* were -7.5p (-1.6%), share buybacks added +17.5p (+3.8%) and expenses and taxes**** were -4.1p (-0.9%).

Β 

Portfolio Net Cash Flow

Β 

PIP's portfolio generated net cash of Β£29.7m over the six-month period, with distributions of Β£111.5m relative to Β£81.8m of calls from existing commitments to private equity funds.

Β 

New Commitments

Β 

PIP made three new investments in the six months to 30 November 2023. In addition to the previously mentioned investments in Commify and Denodo, PIP also made a Β£7.5m co-investment alongside IK Partners in Medica, a provider of teleradiology services with operations in the UK, Ireland and the USA.

Β 

*Figures are stated net of movements associated with the ALN share of the reference portfolio. Valuation movement includes the mark to market fair value adjustment of listed company holdings.

** Ratio of net available cash, portfolio value and undrawn loan facility to outstanding commitments. Outstanding commitments relating to funds outside their investment period (>13 years old) were excluded from the calculation as there is a low likelihood of these being drawn. This amounted to Β£45.1m as at 30 November 2023.

***Based on the change in the ordinary share price over the period.

**** Operating expenses, financing costs and withholding taxes on investment distributions.

^Net available cash calculated as cash and net current assets / (liabilities) less undistributed net cashflows associated with the ALN.

^^Unlisted 10-year note issued on 31 October 2017 whose cost and repayments are linked to a reference portfolio consisting of the Company's older vintage funds.

^^^PIP maintains a Β£500m multi-currency credit facility. The overall loan facility comprises facilities of US$487.7m and ?115.7m and had a sterling equivalent value of Β£485.1m as at 30 November 2023. As at 30 November 2023, PIP had drawn down Β£121m of the loan facility.

Β 

Β 

Corporate Actions

Β 

In October 2023, PIP completed a Β£150m tender offer to purchase its own shares, which resulted in an uplift of 3.5% to the September NAV per share.

Β 

PIP announced a new Β£500m equivalent loan facility to replace the previous loan facility. As a result, the Company has a further strengthened balance sheet with a more sustainable and flexible capital structure.

Β 

Share Buybacks

Β 

PIP invested Β£157.3m in share buybacks (including the tender offer) during the period, acquiring 51,851,801 shares at a weighted- average share price of 303.5p per share. This price represented a weighted average discount of 35.4% to the prevailing NAV per share at the time of the transactions.

Β 

Annualised Performance as at 30 November 2023^^^^

Β 

1 Year (%p.a.)

3 Years

(% p.a.)

5 Years

(% p.a.)

10 Years

(% p.a.)

Since Inception

(% p.a.)

Β 

NAV per share

1.5%

14.9%

12.2%

13.8%

12.0%

Ordinary share price

8.7%

8.2%

7.5%

11.1%

10.8%

FTSE All-Share TR

1.8%

8.4%

4.9%

5.1%

7.3%

MSCI World (Β£) TR

6.8%

9.5%

10.7%

11.7%

8.3%

^^^^PIP was launched on 18 September 1987. The performance figures for PIP assume reinvestment of dividends and capital.

Discrete Performance as at 30 November 2023

Β 

30/11/2018- 30/11/2019

30/11/2019- 30/11/2020

30/11/2020- 30/11/2021

30/11/2021- 30/11/2022

30/11/2022- 30/11/2023

NAV per share

4.7%

12.1%

34.1%

11.5%

1.5%

Ordinary share price

13.4%

-0.2%

37.9%

-15.5%

8.7%

FTSE All-Share TR

11.0%

-10.3%

17.4%

6.5%

1.8%

MSCI World (Β£) TR

13.6%

11.5%

23.4%

-0.5%

6.8%

Β 

Largest Holdings

Β 

Largest managers by value as at 30 November 2023

Β 

Region

% of portfolio

Insight Partners

USA

7.2%

Index Ventures

Global

3.8%

HgCapital

Europe

3.4%

Providence Equity Partners

USA

3.2%

Water Street Healthcare Partners

USA

2.4%

Β 

Β 

Largest companies by value as at 31 August 2023

Β 

Country

Sector

% of portfolio

Action

Netherlands

Consumer

1.2%

ShiftKey

USA

Healthcare

1.0%

Kaseya

Switzerland

Information Technology

1.0%

Valantic

Germany

Information Technology

0.8%

DoIT

Israel

Information Technology

0.7%

Β 

Foreign Exchange Exposure

Β 

At 30 November 2023, the value of the private equity investment assets stood at Β£2,404m. Of the private equity investment assets at PIP's holding level, 77% were represented by funds reporting values denominated in US dollars, 19% denominated in euros, 3% denominated in sterling and 1% denominated in other currencies.

Β 

Of the 77% of investment assets denominated in US dollars, approximately 8% (expressed as a proportion of PIP's total portfolio) are invested in funds investing mainly in Europe and approximately 7% (expressed as a proportion of PIP's total portfolio) in funds investing mainly in Asia.

Β 

As at 30 November 2023, the GBP/USD exchange rate was 1.26570 and the GBP/EUR exchange rate was 1.16010.

Β 

Monthly Report

Β 

The November newsletter can be accessed on PIP's website at www.piplc.com in the Investor Relations section under the heading "Newsletters".

Β 

This announcement contains inside information.

Β 

Ends

Β 

LEI: 2138001B3CE5S5PEE928

Β 

For more information please visit PIP's website at www.piplc.com or contact:

Β 

Pantheon

Helen Steers / Vicki Bradley

Tel: +44 20 3356 1800

Jie Gong

Tel: +852 3718 9605

Follow us on LinkedIn:Β https://www.linkedin.com/company/pantheon-international-plc

Β 

NOTES

Β 

PIP

PIPΒ is aΒ listed FTSE 250 private equity investment trust, overseenΒ by anΒ independent Board of Directors and managed by Pantheon, one of the leading private equity investment managers globally. PIP offers investorsΒ a liquid, differentiated entry point to the excellent growth potential of global private equity, with access to the primary, secondary and co-investment opportunities of some of the best managers in the world. The Company has a track record of NAV outperformance over the long term and manages risk strategically through diversification and rigorous selection based on Pantheon's extensive experience and international platform, and robust investment due diligence and decision-making processes.

Β 

Pantheon

PIP is managed and advised by Pantheon, a leading global private equity, infrastructure & real assets and private debt investor with 40 years' experience sourcing and executing private market investment opportunities on behalf of clients. Pantheon has $94.6 billion in AUM^^^^^ (as at 30 June 2023) and employs approximately 456 staff, including 136 investment professionals (as at 30 September 2023), across offices in London, San Francisco, New York, Chicago, Hong Kong, Seoul, BogotΓ‘, Tokyo, Dublin, Berlin, Geneva and Singapore.

Β 

^^^^^This figure includes assets subject to discretionary or non-discretionary management, advice or those limited to a reporting function.

Β 

Important Information

A copy of this announcement will be available on the Company's website at www.piplc.com. Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.

John Singer CBE

Chair, Pantheon International Plc

Broadwalk House, Southernhay West, Exeter, Devon EX1 1TS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
UPDFLFIDLRISIIS
Date   Source Headline
5th Mar 20201:00 pmRNSChange in Audit Committee Responsibilities
2nd Mar 20203:10 pmEQSHardman & Co Research: Pantheon International Plc (PIN): 2020 interim results: consistency in delivery
27th Feb 20207:00 amRNSHalf-year Report
25th Feb 20207:00 amRNSMonthly Performance Update
24th Jan 20207:00 amRNSMonthly Performance Update
17th Jan 20202:47 pmRNSDirector Declaration
9th Jan 202012:47 pmRNSDirector/PDMR Shareholding
9th Jan 20207:00 amRNSMonthly Performance Update
10th Dec 201911:57 amRNSDirector/PDMR Shareholding
5th Dec 201912:44 pmRNSDirector/PDMR Shareholding
26th Nov 20192:45 pmEQSHardman & Co Research: Pantheon International Plc (PIN): History of value added to portfolio by holding Pantheon
26th Nov 20197:00 amRNSMonthly Performance Update
6th Nov 20194:08 pmRNSDirector/PDMR Shareholding
30th Oct 20195:14 pmRNSResult of AGM
25th Oct 20197:00 amRNSMonthly Performance Update
24th Oct 20195:11 pmRNSDirector Declaration
26th Sep 20197:00 amRNSMonthly Performance Update
9th Sep 20197:00 amRNSAppointment of Non-Executive Director
6th Sep 20197:30 amEQSHardman & Co Research: Pantheon International Plc (PIN) - (Initiation of coverage): 11.9% average annual NAV growth since 1987
22nd Aug 20197:00 amRNSMonthly Performance Update
8th Aug 20192:41 pmRNSDirector/PDMR Shareholding
7th Aug 20197:05 amRNSAnnual Financial Report
7th Aug 20197:00 amRNSAppointment of Non-Executive Director
26th Jul 20197:00 amRNSMonthly Performance Update
11th Jul 20197:00 amRNSMonthly Performance Update
22nd May 20197:00 amRNSMonthly Performance Update
26th Apr 20197:00 amRNSMonthly Performance Update
26th Mar 20197:00 amRNSMonthly Performance Update
27th Feb 20197:00 amRNSHalf-year Report
26th Feb 20197:00 amRNSMonthly Performance Update
1st Feb 201911:37 amRNSTotal Voting Rights
25th Jan 20197:00 amRNSMonthly Performance Update
10th Jan 20196:05 pmRNSTotal Voting Rights
10th Jan 20196:03 pmRNSTransaction in Own Shares
10th Jan 201911:54 amRNSDirector/PDMR Shareholding
10th Jan 20197:00 amRNSMonthly Performance Update
23rd Nov 20187:00 amRNSMonthly Performance Update
31st Oct 201812:02 pmRNSResult of AGM
23rd Oct 20187:00 amRNSMonthly Performance Update
26th Sep 20187:00 amRNSMonthly Performance Update
22nd Aug 20187:00 amRNSMonthly Performance Update
8th Aug 20187:00 amRNSAnnual Financial Report
31st Jul 20187:00 amRNSMonthly Performance Update
12th Jul 20187:00 amRNSMonthly Performance Update
11th Jul 201812:43 pmRNSDirector Declaration
5th Jun 20185:01 pmRNSDirector/PDMR Shareholding
4th Jun 20189:08 amRNSRenewal of Credit Facility
1st Jun 20182:44 pmRNSDirector/PDMR Shareholding
23rd May 20187:00 amRNSMonthly Performance Update
24th Apr 20187:00 amRNSMonthly Performance Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.